The Court of Justice of the EU has confirmed that a number of health claims relating to the benefits of glucose to the metabolism cannot be authorised, without mentioning the possible dangers resulting from ambiguous or misleading information provided to consumers. These claims can therefore not be used when these products are being presented.
In a decision made on Thursday 8 June (C-296/16 P), the Court dismissed the company Dextro Energy’s appeal against the judgment of the General Court...